MX2009004258A - Vacuna profilactica contra la tuberculosis. - Google Patents

Vacuna profilactica contra la tuberculosis.

Info

Publication number
MX2009004258A
MX2009004258A MX2009004258A MX2009004258A MX2009004258A MX 2009004258 A MX2009004258 A MX 2009004258A MX 2009004258 A MX2009004258 A MX 2009004258A MX 2009004258 A MX2009004258 A MX 2009004258A MX 2009004258 A MX2009004258 A MX 2009004258A
Authority
MX
Mexico
Prior art keywords
tuberculosis
mtb
tuberculosis vaccine
virulent
prophylactic
Prior art date
Application number
MX2009004258A
Other languages
English (en)
Inventor
Iglesias Pere Joan Cardona
Riera Isabel Amat
Original Assignee
Archivel Farma Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archivel Farma Sl filed Critical Archivel Farma Sl
Publication of MX2009004258A publication Critical patent/MX2009004258A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención concierne al uso de un agente inmunoterápico que comprende fragmentos de pared celular de una cepa virulenta de Mycobacterium tuberculosis-complex (MTB-C) para la preparación de un medicamento para el tratamiento profiláctico de la tuberculosis, en donde dicho agente es obtenible por un procedimiento que comprende las siguientes etapas: cultivar la cepa virulenta MTB-C durante un período de tiempo igual o superior a tres semanas; y, posteriormente, homogeneizar el cultivo de células en presencia de un tensioactivo no iónico.
MX2009004258A 2006-10-30 2007-10-17 Vacuna profilactica contra la tuberculosis. MX2009004258A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200602754A ES2307402B1 (es) 2006-10-30 2006-10-30 Vacuna profilactica contra la tuberculosis.
PCT/ES2007/000583 WO2008053055A1 (es) 2006-10-30 2007-10-17 Vacuna profiláctica contra la tuberculosis

Publications (1)

Publication Number Publication Date
MX2009004258A true MX2009004258A (es) 2009-05-11

Family

ID=39343853

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004258A MX2009004258A (es) 2006-10-30 2007-10-17 Vacuna profilactica contra la tuberculosis.

Country Status (20)

Country Link
US (1) US9289483B2 (es)
EP (1) EP2090318B1 (es)
JP (1) JP2010508254A (es)
KR (1) KR20090087874A (es)
CN (1) CN101600455B (es)
AU (1) AU2007316091B2 (es)
BR (1) BRPI0715297B8 (es)
CA (1) CA2667965C (es)
DK (1) DK2090318T3 (es)
ES (2) ES2307402B1 (es)
HK (1) HK1138786A1 (es)
IL (1) IL198357A (es)
MX (1) MX2009004258A (es)
NZ (1) NZ576489A (es)
PL (1) PL2090318T3 (es)
PT (1) PT2090318E (es)
RU (1) RU2526910C2 (es)
UA (1) UA104126C2 (es)
WO (1) WO2008053055A1 (es)
ZA (1) ZA200902937B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.
CN104744476B (zh) 2008-12-08 2017-04-12 吉利德康涅狄格公司 咪唑并吡嗪syk抑制剂
JP5696052B2 (ja) 2008-12-08 2015-04-08 ギリアード コネチカット， インコーポレイテッド イミダゾピラジンｓｙｋ阻害剤
EP2471511A1 (en) 2011-01-04 2012-07-04 Archivel Farma, SL Liposome formulation suitable for treating or preventing tuberculosis
BR112013017267B1 (pt) 2011-01-04 2021-06-22 Archivel Farma, Sl Formulação de lipossomas, suspensão e composição farmacêutica
DK2802345T3 (en) * 2012-01-12 2018-04-30 Archivel Farma Sl MTB-C-VACCINE AGAINST ALLERGIC REACTIONS
KR20210131372A (ko) 2019-02-22 2021-11-02 크로노스 바이오, 인코포레이티드 Syk 억제제로서의 축합된 피라진의 고체 형태
WO2023062066A1 (en) 2021-10-14 2023-04-20 Archivel Farma, S.L. Liposome formulations for treatment of active tuberculosis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641814B1 (en) * 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
RU2093046C1 (ru) * 1996-05-06 1997-10-20 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Лечебно-профилактическая пищевая композиция "гербамарин"
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AP9901670A0 (en) * 1997-03-03 1999-12-31 Adcock Ingram Ltd A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease.
US7037510B2 (en) * 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
EP1117683A2 (en) 1998-10-08 2001-07-25 Statens Serum Institut Tb vaccine and diagnostic based on antigens from the m. tuberculosis cell
RU2153354C1 (ru) * 1999-03-31 2000-07-27 Московский городской научно-практический центр борьбы с туберкулезом Вакцина против туберкулеза
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
WO2002045736A1 (en) * 2000-12-08 2002-06-13 The Johns Hopkins University Methods for improved diagnosis and treatment of mycobacterial infections
EP2196473A1 (en) 2001-07-04 2010-06-16 Health Protection Agency Mycobacterial antigens expressed during latency
ZA200400843B (en) * 2001-08-02 2007-11-28 Univ New York Early detection of mycobacterial disease using peptides
WO2003018053A1 (en) 2001-08-22 2003-03-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccine against mycobacterial-induced diseases
BR0307262A (pt) * 2002-01-29 2006-12-19 Bakulesh Mafatlal Khamar método de prover profilaxia para tuberculose em indivìduos hiv positivos
CN1467221A (zh) * 2002-07-14 2004-01-14 虹 王 结核杆菌cfp-10、esat-6与cd40l融合疫苗的制备及应用
ES2231037B1 (es) * 2003-10-31 2005-12-16 Archivel Technologies, Sl Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos.
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.

Also Published As

Publication number Publication date
IL198357A0 (en) 2011-08-01
HK1138786A1 (en) 2010-09-03
ES2393007T3 (es) 2012-12-17
CN101600455B (zh) 2013-08-07
US9289483B2 (en) 2016-03-22
IL198357A (en) 2013-03-24
KR20090087874A (ko) 2009-08-18
CA2667965C (en) 2016-08-23
BRPI0715297B8 (pt) 2021-05-25
DK2090318T3 (da) 2012-11-19
JP2010508254A (ja) 2010-03-18
EP2090318A1 (en) 2009-08-19
ES2307402B1 (es) 2009-09-30
EP2090318B1 (en) 2012-08-08
RU2009120522A (ru) 2013-01-20
AU2007316091B2 (en) 2013-06-27
PT2090318E (pt) 2012-11-14
AU2007316091A1 (en) 2008-05-08
BRPI0715297B1 (pt) 2019-01-29
RU2526910C2 (ru) 2014-08-27
US20100068258A1 (en) 2010-03-18
NZ576489A (en) 2012-02-24
EP2090318A4 (en) 2010-01-27
PL2090318T3 (pl) 2013-03-29
ZA200902937B (en) 2010-02-24
WO2008053055A1 (es) 2008-05-08
ES2307402A1 (es) 2008-11-16
BRPI0715297A2 (pt) 2015-02-03
CA2667965A1 (en) 2008-08-05
UA104126C2 (ru) 2014-01-10
CN101600455A (zh) 2009-12-09

Similar Documents

Publication Publication Date Title
UA104126C2 (ru) Профилактическая вакцина от туберкулеза
WO2010019262A3 (en) Polyvalent vaccine
WO2007024941A3 (en) Polyvalent vaccine
IN2012DN01898A (es)
MX2010005642A (es) Preparados, metodos y estuches para el tratamiento de la tos.
WO2008039874A3 (en) Cancer stem cell antigen vaccines and methods
MX2012005863A (es) Formulaciones de anticuerpos.
NZ616304A (en) Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
PH12014501835A1 (en) Novel adjuvant compositions
EP2588592A4 (en) USE OF PERFUSION DECELLULARIZED ORGANS FOR AGGREGATE RECELLULARIZATION
AU2010203451A8 (en) Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
MA32819B1 (fr) Vaccin combine notamment contre la coqueluche acellulaire
CA2763359C (en) New human rotavirus strains and vaccines
WO2006099360A3 (en) Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
CL2011000913A1 (es) Vacuna combinada estable y completamente liquida que comprende antigenos difterico, tetanico, pertusico de celulas completas, y virus de poliomielitis y opcionalmente uno o mas antigenos seleccionados entre haemophilus influenzae y hepatitis; y proceso de fabricacion.
WO2008048344A3 (en) Bacillus anthracis antigens, vaccine compositions, and related methods
WO2012065135A3 (en) Immunomodulatory compositions, methods and systems comprising immunogenic fragments of apob100
UA114286C2 (uk) Спосіб лікування staphylococcus aureus
AU2007272785A8 (en) Methods to elicit, enhance and sustain immune responses against MHC class-I restricted epitopes, for prophylactic or therapeutic purposes
NZ589981A (en) Cattle vaccines comprising a disrupted M. bovis bacterium
EP2597151A4 (en) RECOMBINANT MICROORGANISMS, METHODS FOR THE PREPARATION OF VACCINE STRAINS, ANTIGENS, VECTORIZED VACCINE COMPOSITIONS, USES THEREOF, ANTIBODIES, DIAGNOSTIC KIT AND METHODS OF TREATMENT AND / OR PROPHYLAXIS
BR112013001168A2 (pt) "toxóide, composição farmacêutica, método de produzir uma antitoxina, antitoxina, e, métodos de tratar um indivíduo intoxicado de vacinação contra a intoxicação por uma toxina e de tratar um mamífero intoxicado."
DE60336588D1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
WO2010006326A3 (en) Methods and compositions for spore-based vaccines
WO2022218891A3 (en) Rna compositions comprising a buffer substance and methods for preparing, storing and using the same

Legal Events

Date Code Title Description
FG Grant or registration